Search Result "selective PPARδ agonists."
Synthesis, Docking and Evaluation of Phenylacetic Acid and Trifluoro-methylphenyl Substituted Benzamide Derivatives as Potential PPARδ Agonists
Journal: Letters in Drug Design & Discovery
Volume: 14 Issue: 11 Year: 2017 Page: 1239-1251
Author(s): Ajmer Singh Grewal,Viney Lather,Deepti Pandita,Garima Bhayana
Recent Updates on Peroxisome Proliferator-Activated Receptor δ Agonists for the Treatment of Metabolic Syndrome
Journal: Medicinal Chemistry
Volume: 12 Issue: 1 Year: 2016 Page: 3-21
Author(s): Ajmer S. Grewal,Meenu Beniwal,Deepti Pandita,Bhupinder S. Sekhon,Viney Lather
Balaglitazone: A Second Generation Peroxisome Proliferator-Activated Receptor (PPAR) Gamma (γ) Agonist
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 12 Issue: 2 Year: 2012 Page: 87-97
Author(s): R. Agrawal, P. Jain, S. N. Dikshit
A PPARdelta Agonist Reduces Amyloid Burden and Brain Inflammation in a Transgenic Mouse Model of Alzheimers Disease
Journal: Current Alzheimer Research
Volume: 6 Issue: 5 Year: 2009 Page: 431-437
Author(s): Sergey Kalinin, Jill C. Richardson, Douglas L. Feinstein
Recent Progress of Medicinal Chemistry Research on Peroxisome Proliferator-Activated Receptor (PPAR) Ligands for the Treatment of Metabolic Syndrome
Journal: Current Bioactive Compounds
Volume: 2 Issue: 2 Year: 2006 Page: 151-159
Author(s): Hiroyuki Miyachi
Enantioselective Synthesis of PPAR (Peroxisome Proliferator-Activated Receptors) Agonists and Antagonists
Journal: Current Topics in Medicinal Chemistry
Volume: 14 Issue: 10 Year: 2014 Page: 1283-1293
Author(s): Pilar Goya,Ruth Perez-Fernandez,Rosario Gonzalez-Muniz,Jose Elguero
Fine Tuning of PPAR Ligands for Type 2 Diabetes and Metabolic Syndrome
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 6 Issue: 5 Year: 2006 Page: 563-573
Author(s): Uma Ramachandran, Rakesh Kumar, Amit Mittal
Peroxisome Proliferator-Activated Receptor (PPAR) Agonists as Promising New Medications for Drug Addiction: Preclinical Evidence
Journal: Current Drug Targets
Volume: 14 Issue: 7 Year: 2013 Page: 768-776
Author(s): Bernard Le Foll, Patricia Di Ciano, Leigh V. Panlilio, Steven R. Goldberg, Roberto Ciccocioppo
Use of Clinically Available PPAR Agonists for Heart Failure; Do the Risks Outweigh the Potential Benefits?
Journal: Current Molecular Pharmacology
Volume: 5 Issue: 2 Year: 2012 Page: 255-263
Author(s): Satyam Sarma
Ameliorative Effects of GW1929, a Nonthiazolidinedione PPARγ Agonist,on Inflammation and Apoptosis in Focal Cerebral Ischemic-Reperfusion Injury
Journal: Current Neurovascular Research
Volume: 8 Issue: 3 Year: 2011 Page: 236-245
Author(s): Ravinder K. Kaundal, Shyam S. Sharma